J L Nielsen Selected Research

J L Nielsen Research Topics

5	Multiple Myeloma 04/2009 - 01/2000
2	Bone Diseases (Bone Disease) 10/2001 - 02/2000
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Muscle Weakness 01/2017
1	Multiple Sclerosis 11/2016
1	Inclusion Body Myositis 11/2016
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 09/2008
1	Diarrhea 09/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2008
1	Nausea 09/2008
1	Anorexia 09/2008
1	Lymphoma (Lymphomas) 03/2007
1	Blast Crisis (Blast Phase) 11/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2001
1	Necrosis 02/2000
1	Bone Resorption 02/2000

2	CytokinesIBA 04/2009 - 02/2000
1	4-Aminopyridine (4 Aminopyridine)FDA Link 11/2016
1	lonafarnib (SCH 66336)IBA 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	Imatinib Mesylate (Gleevec)FDA Link 11/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2001
1	RANK LigandIBA 10/2001
1	OsteoprotegerinIBA 10/2001
1	deoxypyridinolineIBA 02/2000
1	collagen type I trimeric cross-linked peptideIBA 02/2000
1	CollagenIBA 02/2000
1	Diphosphonates (Bisphosphonates)IBA 02/2000
1	pyridinolineIBA 02/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2000
1	Biomarkers (Surrogate Marker)IBA 02/2000
1	Interleukin-6 (Interleukin 6)IBA 02/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2000
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2000